IL-33 exacerbates acute kidney injury

Journal of the American Society of Nephrology

Volumn 22, Issue 11, 2011, Pages 2057-2067

  Akcay, Ali ^a   Nguyen, Quocan ^a   He, Zhibin ^a   Turkmen, Kultigin ^a   Lee, Dong Won ^a   Hernando, Ana Andres ^a   Altmann, Christopher ^a   Toker, Aysun ^a   Pacic, Arijana ^b   Ljubanovic, Danica Galesic ^b   Jani, Alkesh ^a   Faubel, Sarah ^a   Edelstein, Charles L ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE; CXCL1 CHEMOKINE; DECOY RECEPTOR 3; INTERLEUKIN 33; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 33; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 80555146721     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010091011     Document Type: Article

References (46)

1. Schrier RW: Cancer therapy and renal injury. J Clin Invest 110: 743-745, 2002
2. Safirstein RL: Renal disease induced by anti-neoplastic agents. In: Diseases of the Kidney and Urinary Tract, 8th ed., edited by Schrier RW, Philadelphia, Lippincott, Williams and Wilkins, 2007, pp. 1068-1081
3. Faubel SG, Ljubanovic D, Reznikov LL, Somerset H, Dinarello CA, Edelstein CL: Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int 66: 2202-2213, 2004 (Pubitemid 41115283)
4. Moussion C, Ortega N, Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel "alarmin"? PLoS ONE 3: e3331, 2008
5. Lamkanfi M, Dixit VM: IL-33 raises alarm. Immunity 31: 5-7, 2009
6. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, Lavelle EC, Martin SJ: Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98, 2009
7. Cayrol C, Girard JP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106: 9021-9026, 2009
8. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G: Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 284: 19420-19426, 2009
9. Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm. E pub, 2010
10. Liu M, Chien CC, Burne-Taney M, Molls RR, Racusen LC, Colvin RB, Rabb H: A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 17: 765-774, 2006
11. Dinarello CA: An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 23: 461-462, 2005
12. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, Pitman N, Mirchandani A, Rana B, Van Rooijen N, Shepherd M, McSharry C, McInnes IB, Xu D, Liew FY: IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183: 6469-6477, 2009
13. Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY: IL-33 is a chemoattractant for human Th2 cells. European J Immunol 37: 2779-2786, 2007 (Pubitemid 47578297)
14. Liew FY, Pitman N, McInnes IB: Disease-associated functions of IL-33: The new kid in the IL-1 family. Nat Rev Immunol 10: 103-109, 2010
15. Dursun B, He Z, Somerset H, Oh DJ, Faubel S, Edelstein CL: Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am J Physiol Renal Physiol 291: F578-F587, 2006 (Pubitemid 44343739)
16. Sheikh-Hamad D: Cisplatin-induced cytoxicity: Is the nucleus relevant? Am J Physiol Renal Physiol 295: F42-43, 2008
17. Sartori S, Nielsen I, Maestri A, Beltrami D, Trevisani L, Pazzi P: Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study. Oncology 48: 356-361, 1991
18. Wang J, He D, Zhang Q, Han Y, Jin S, Qi F: Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother Radiopharm 24: 675-680, 2009
19. Leo F, Pelosi G, Sonzogni A, Chilosi M, Bonomo G, Spaggiari L: Structural lung damage after chemotherapy fact or fiction? Lung Cancer 67: 306-310, 2010
20. Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H, Oh DJ, Lu L, Klein CL, Dinarello CA, Edelstein CL: Cisplatin-induced ARF is associated with an increase in the cytokines IL-1β, IL-18, IL-6 and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 322: 8-15, 2007 (Pubitemid 46956357)
21. Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M: ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Therap 112: 139-149, 2006 (Pubitemid 44314001)
22. Stillie R, Farooq SM, Gordon JR, Stadnyk AW: The functional significance behind expressing two IL-8 receptor types on PMN. Journal of Leukoc Biol 86: 529-543, 2009
23. He Z, Altmann C, Hoke TS, Ljubanovic D, Jani A, Dinarello CA, Faubel S, Edelstein CL: Interleukin-18 (IL-18) binding protein transgenic mice are protected against ischemic AKI. Am J Physiol Renal Physiol 295: F1414-F1421, 2008
24. Kakkar R, Lee RT: The IL-33/ST2 pathway: Therapeutic target and novel biomarker. Nat Rev Drug Discov 7: 827-840, 2008
25. Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, Baker AH, McInnes IB, Liew FY: IL-33 reduces the development of atherosclerosis. J Exp Med 339-346, 2005 (Pubitemid 351281600)
26. Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RT: Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109: 2186-2190, 2004 (Pubitemid 38625395)
27. Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT: Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107: 721-726, 2003 (Pubitemid 36222600)
28. Matsuyama Y, Okazaki H, Tamemoto H, Kimura H, Kamata Y, Nagatani K, Nagashima T, Hayakawa M, Iwamoto M, Yoshio T, Tominaga S, Minota S: Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheum 37: 18-25, 2010
29. Lu L, Oh DJ, Dursun B, He Z, Hoke TS, Faubel S, Edelstein CL: Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J Pharmacol Exp Ther 324: 111-117, 2007 (Pubitemid 350294166)
30. Jackson AM, Rose BD, Graff LG, Jacobs JB, Schwartz JH, Strauss GM, Yang JP, Rudnick MR, Elfenbein IB, Narins RG: Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 101: 41-44, 1984 (Pubitemid 14088065)
31. Fields SM, Lindley CM: Thrombotic microangiopathy associated with chemotherapy: case report and review of the literature. DICP 23: 582-588, 1989 (Pubitemid 19189946)
32. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP: IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104: 282-287, 2007 (Pubitemid 46068023)
33. Hayakawa M, Hayakawa H, Matsuyama Y, Tamemoto H, Okazaki H, Tominaga S: Mature IL-33 is produced by calpain-mediated cleavage in vivo. Biochem Biophys Res Comm 387: 218-222, 2009
34. Smith DE: IL-33: A tissue derived cytokine pathway in allergic inflammation and asthma. Clin Exp Allergy 40: 200-208, 2009
35. Lee H, Nho D, Chung HS, Lee H, Shin MK, Kim SH, Bae H: CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int 78: 1100-1109, 2010
36. Ramesh G, Reeves WB: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842, 2002
37. Ramesh G, Reeves WB: TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 285: F610-F618, 2003 (Pubitemid 37140245)
38. Franchi L, Eigenbrod T, Nunez G: Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183: 792-796, 2009
39. Bolisetty S, Agarwal A: Neutrophils in acute kidney injury: Not neutral any more. Kidney Int75: 674-676, 2009
40. Gangadharan C, Thoh M, Manna SK: Late phase activation of NFKB by doxorubicin is mediated by IL-8 and induction of apoptosis via FasL. Breast Cancer Res Treat 120: 671-683, 2010
41. Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH: Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 11: 454-467, 2000 (Pubitemid 30115075)
42. Faubel SG, Ljubanovic D, Poole B, Dursun B, Cushing S, He Z, Gill RG, Edelstein CL: Peripheral CD4 T cell depletion is not sufficient to prevent ischemic acute renal failure. Transplant 80: 643-649, 2005 (Pubitemid 41377752)
43. Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch FW: Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131: 2445-2451, 1983 (Pubitemid 14230079)
44. Vielhauer V, Anders HJ, Perez dL, Luckow B, Schlondorff D, Mack M: Phenotyping renal leukocyte subsets by four-color flow cytometry: Characterization of chemokine receptor expression. Nephron Exp Nephrol 93: e63, 2003
45. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM: Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 172: 2853-2860, 2004 (Pubitemid 38263670)
46. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW: Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265: 682-684, 1994 (Pubitemid 24268283)